Reported positive data from the Phase II MAvERIC-Pilot study investigating the impact of CardiolRx™ administered to patients with symptomatic recurrent pericarditis; results support advancing to the ...

Corcept's relacorilant hits phase 3 trial success in ovarian cancer, lifting shares 90%. Click here to find out why I rate ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders, today announced the enrollment of ...

Learn more about whether Corcept Therapeutics Incorporated or Zoetis Inc. is a better investment based on AAII's A+ Investor ...

Learn more about whether Corcept Therapeutics Incorporated or Haleon plc is a better investment based on AAII's A+ Investor ...

Strengthened Leadership and Expanded U.S. Presence Positions SynOx for Regulatory Filings and Commercialization of Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT) DUBLIN, Ireland and OXFORD, ...

Jaguar Health, Inc. (NASDAQ:JAGX) (”Jaguar” or “the Company”), today announced the closing of its previously announced private placement.

In a groundbreaking discussion among leading psychiatrists in Mumbai, non-conventional approaches to stress and anxiety ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is still trading at three-year highs, despite current market volatility, in ...